| Dr Stanley Feero, MD | |
|
413 Lilly Rd Ne, Olympia, WA 98506-5133 | |
| (360) 491-9480 | |
| Not Available |
| Full Name | Dr Stanley Feero |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 413 Lilly Rd Ne, Olympia, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134166374 | NPI | - | NPPES |
| A006 | Other | CHAMPUS | |
| 168549 | Other | WA L&I | |
| 8543803 | Medicaid | WA | |
| 268743 | Medicaid | OR | |
| 8935585 | Other | WA CRIME VICTIMS | |
| A21185 | Other | GROUP HEALTH | |
| FE3368 | Other | REGENCE BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00016109 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stanley Feero, MD Po Box 5007, Lacey, WA 98509-5007 Ph: (800) 599-0166 | Dr Stanley Feero, MD 413 Lilly Rd Ne, Olympia, WA 98506-5133 Ph: (360) 491-9480 |
News Archive
Rubicon Genomics, Inc. today announced the launch of its PicoPLEX DNA-seq Kits for use with Illumina next-generation sequencing (NGS) platforms. PicoPLEX's outstanding robustness and reproducibility have made it the worldwide standard for single-cell DNA amplification for microarray and PCR-based pre-implantation genetic screening and diagnosis. PicoPLEX DNA-seq now enables researchers and clinicians to access PicoPLEX technology for analyses conducted on Illumina NGS systems.
Neighborhood resources to support greater physical activity and, to a lesser extent, healthy diets appear to be associated with a lower incidence of type 2 diabetes, although the results vary by the method of measurement used, according to an article published online by JAMA Internal Medicine.
Mylan Laboratories has announced that U.S. Patent No. 7,070,808 was issued to its subsidiary, Mylan Technologies Inc. (MTI), on July 4, 2006.
The one-child policy seeks to keep China's population, now 1.3 billion, at around 1.7 billion by 2050. Ethnic minorities and farmers are the only groups legally exempt from the rule.
Fitch Ratings sees an active year for new drug applications to be registered to U.S. and European drug regulators considering recent updates to the pharmaceutical industry's late-stage R&D programs. According to Fitch's new Global Pharmaceutical R&D Pipeline report, the Fitch-rated pharmaceutical developers listed in the report plan on submitting marketing applications to the U.S. Food & Drug Administration (FDA) or the European Medicines Agency (EMEA) during 2010 for approval of 22 novel drug therapies.
› Verified 4 days ago
Dr. Jeffrey Howard, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 413 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-491-9480 | |
Dr. Penelope Anne Goode, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 413 Lilly Rd Ne, Olympia Emergency Services, Olympia, WA 98506 Phone: 360-493-4554 | |
Susan A Derry, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 413 Lilly Rd Ne, Msddh09, Olympia, WA 98506 Phone: 360-918-0119 | |
Dr. Lien Hong Ly, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 | |
Dr. Bruce Lincoln, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 413 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-491-9480 | |
Daniel Gilday, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 413 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-493-4400 | |
Dr. Joshua James Sahara, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7318 Grayhawk Ln Ne, Olympia, WA 98516 Phone: 914-217-4372 |